Haemonetics Corp Earnings

Haemonetics Corp’s revenue fell -4.4% since last year same period to $321.39Mn in the Q2 2025. On a quarterly growth basis, Haemonetics Corp has generated -2.78% fall in its revenue since last 3-months.

Haemonetics Corp’s net profit fell -11.32% since last year same period to $34.03Mn in the Q2 2025. On a quarterly growth basis, Haemonetics Corp has generated -41.31% fall in its net profits since last 3-months.

Haemonetics Corp’s net profit margin fell -7.24% since last year same period to 10.59% in the Q2 2025. On a quarterly growth basis, Haemonetics Corp has generated -39.63% fall in its net profit margins since last 3-months.

Haemonetics Corp’s earning per share (EPS) estimates for the current quarter stand at 1.11 - a 8.82% jump from last quarter’s estimates.

Haemonetics Corp’s earning per share (EPS) estimates for the current year stand at 1.11.

Haemonetics Corp’s earning per share (EPS) jumped 7.84% since last year same period to 1.1 in the Q2 2025. This indicates that the Haemonetics Corp has generated 7.84% annual rate of jump in its earning per share (EPS) in the last 4 quarters.